Literature DB >> 24491024

Long-term effect of curcumin down-regulates expression of tumor necrosis factor-α and interleukin-6 via modulation of E26 transformation-specific protein and nuclear factor-κB transcription factors in livers of lymphoma bearing mice.

Laxmidhar Das1, Manjula Vinayak.   

Abstract

Tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) are typical multifunctional proinflammatory cytokines involved actively in the regulation of immunity, hematopoiesis, inflammation and carcinogenesis. Coordinated regulation of these cytokines could be required for effective regulation of early phase inflammation and cancer progression. The present work was aimed to analyze the anti-carcinogenic action of curcumin on the expression of TNF-α and IL-6 even after withdrawal of treatment. Up-regulated expressions of TNF-α and IL-6 in terms of mRNA and protein levels in lymphoma bearing mice were significantly down-regulated by curcumin as compared to normal. Electrophoretic mobility shift assay (EMSA) results revealed that curcumin reduced binding of nuclear protein with ETS and NF-κB binding elements of TNF-α and IL-6 promoters, respectively. The anti-carcinogenic effect of curcumin against lymphoma progression has been reported previously. In continuation, the present study suggests that the long-term effect of curcumin may contribute to attenuate cancer progression via the down-regulation of TNF-α and IL-6 modulated by E26 transformation-specific protein (ETS) and nuclear factor-κB (NF-κB), respectively.

Entities:  

Keywords:  Lymphoma; carcinogenesis; curcumin; cytokines; microenvironment

Mesh:

Substances:

Year:  2014        PMID: 24491024     DOI: 10.3109/10428194.2014.889824

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  10 in total

1.  Thymidine kinase gene delivery using curcumin loaded peptide micelles as a combination therapy for glioblastoma.

Authors:  Jin Hyeong Park; Jaesik Han; Minhyung Lee
Journal:  Pharm Res       Date:  2014-08-27       Impact factor: 4.200

Review 2.  Curcumin a potent cancer preventive agent: Mechanisms of cancer cell killing.

Authors:  Muobarak Jaber Tuorkey
Journal:  Interv Med Appl Sci       Date:  2014-12-22

3.  IL-6, through p-STAT3 rather than p-STAT1, activates hepatocarcinogenesis and affects survival of hepatocellular carcinoma patients: a cohort study.

Authors:  Jung-Ta Kao; Chun-Lung Feng; Cheng-Ju Yu; Shu-Mei Tsai; Ping-Ning Hsu; Yao-Li Chen; Yi-Ying Wu
Journal:  BMC Gastroenterol       Date:  2015-04-25       Impact factor: 3.067

4.  Reduction of delayed onset muscle soreness by a novel curcumin delivery system (Meriva®): a randomised, placebo-controlled trial.

Authors:  Franchek Drobnic; Joan Riera; Giovanni Appendino; Stefano Togni; Federico Franceschi; Xavier Valle; Antoni Pons; Josep Tur
Journal:  J Int Soc Sports Nutr       Date:  2014-06-18       Impact factor: 5.150

5.  Long term effect of curcumin in restoration of tumour suppressor p53 and phase-II antioxidant enzymes via activation of Nrf2 signalling and modulation of inflammation in prevention of cancer.

Authors:  Laxmidhar Das; Manjula Vinayak
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

Review 6.  The multifaceted role of curcumin in cancer prevention and treatment.

Authors:  Muthu K Shanmugam; Grishma Rane; Madhu Mathi Kanchi; Frank Arfuso; Arunachalam Chinnathambi; M E Zayed; Sulaiman Ali Alharbi; Benny K H Tan; Alan Prem Kumar; Gautam Sethi
Journal:  Molecules       Date:  2015-02-05       Impact factor: 4.411

7.  Curcumin induced oxidative stress attenuation by N-acetylcysteine co-treatment: a fibroblast and epithelial cell in-vitro study in idiopathic pulmonary fibrosis.

Authors:  L R Rodriguez; S N Bui; R T Beuschel; E Ellis; E M Liberti; M K Chhina; B Cannon; M Lemma; S D Nathan; G M Grant
Journal:  Mol Med       Date:  2019-06-13       Impact factor: 6.354

8.  Long term effect of curcumin in regulation of glycolytic pathway and angiogenesis via modulation of stress activated genes in prevention of cancer.

Authors:  Laxmidhar Das; Manjula Vinayak
Journal:  PLoS One       Date:  2014-06-16       Impact factor: 3.240

Review 9.  Polymeric Nanocarriers of Drug Delivery Systems in Cancer Therapy.

Authors:  Nataša Avramović; Boris Mandić; Ana Savić-Radojević; Tatjana Simić
Journal:  Pharmaceutics       Date:  2020-03-25       Impact factor: 6.321

10.  Curcumin attenuates prostatic hyperplasia caused by inflammation via up-regulation of bone morphogenetic protein and activin membrane-bound inhibitor.

Authors:  Yuhang Liu; Zhaohui Wang; Yu Gan; Xiang Chen; Bo Zhang; Zhi Chen; Peihuan Liu; Bingsheng Li; Feng Ru; Yao He
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.